. Author manuscript; available in PMC: 2023 Jun 1.

Published in final edited form as: Jt Comm J Qual Patient Saf. 2022 Apr 2;48(6-7):335–342. doi: 10.1016/j.jcjq.2022.03.002

Table 3.

Descriptive Review of Potential Factors Contributing to Confirmed Delays in HbA1c Testing for Patients with Uncontrolled Diabetes (N = 93)

Communication of result^* [HbA1c >9%] (N [%])
Any communication attempted	91 (98)
Attempted within 30 days	89 (96)
Method of communication (N = 91)^*
In-person	66 (73)
Electronic message	7 (8)
Telephone call	5 (5)
Letter	13 (14)
Follow-up ^*
Appointment scheduled	69 (74)
Missed appointment (N = 69)^†	59 (86)
No show^‡	30 (44)
Patient cancellation^‡	37 (54)
Recommendations^* (N [%])
Any management recommendations	78 (84)
Treatment recommendations (N=78)
New medications	37 (47)
Medication dose change	30 (38)
Medication adherence	15 (19)
Lifestyle modification	47 (60)
Referral to specialist	23 (29)
Any recommendations for diagnostic testing	45 (48)
Diagnostic testing recommendations (N = 45)
Repeat HbA1c	9 (20)
Self-monitoring	42 (93)

Within 6 months of test result.

^†

At least one instance without successful rescheduling within 6 months of test result.

^‡

A single patient could have both no shows and cancellations.